| Literature DB >> 30963289 |
Christina K Cramer1, Tiffany L Cummings2, Rachel N Andrews3, Roy Strowd4, Stephen R Rapp5, Edward G Shaw6, Michael D Chan7, Glenn J Lesser8.
Abstract
OPINION STATEMENT: Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally accompanied by a decline in functional independence and performance status. Cognitive decline can be a result of tumor progression, depression/anxiety, fatigue/sleep dysfunction, or the treatments they have received. It is our opinion that providers treating brain tumor patients should obtain pre-treatment and serial cognitive testing in their patients and offer mitigating and therapeutic interventions when appropriate. They should also support cognition-focused clinical trials.Entities:
Keywords: Attention; Brain; Cognition; Memory; Neuropsychology; Radiation
Year: 2019 PMID: 30963289 PMCID: PMC6594685 DOI: 10.1007/s11864-019-0641-6
Source DB: PubMed Journal: Curr Treat Options Oncol ISSN: 1534-6277